Microbiology of cystic fibrosis lung infections: themes and issues (Q72082088)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684788%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

review article

1 reference

title

Microbiology of cystic fibrosis lung infections: themes and issues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684788%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

Govan JR

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684788%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Nelson JW

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684788%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684788%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Royal Society of Medicine

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684788%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

86 Suppl 20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684788%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

11-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684788%20AND%20SRC:MED&resulttype=core&format=json

Pseudomonas cepacia in inpatients with cystic fibrosis

23 October 2019

cites work

1 reference

12 December 2020

Longitudinal serum IgG response toPseudomonas cepacia surface antigens in cystic fibrosis

1 reference

12 December 2020

Pseudomonas cepacia infection in cystic fibrosis

1 reference

12 December 2020

Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis

1 reference

12 December 2020

Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis

1 reference

12 December 2020

Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid form to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro

1 reference

12 December 2020

IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis

1 reference

12 December 2020

Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source

1 reference

12 December 2020

Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells

1 reference

12 December 2020

Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin

1 reference

12 December 2020

Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results

1 reference

12 December 2020

Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis

1 reference

12 December 2020

Tracheobronchial mucin receptor for Pseudomonas aeruginosa: predominance of amino sugars in binding sites.

1 reference

12 December 2020

Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist

1 reference

12 December 2020

Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis

1 reference

12 December 2020

The role of immune complexes in the pathogenesis of bacterial infections

1 reference

12 December 2020

Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis

1 reference

12 December 2020

Pseudomonas aeruginosa adhesins for tracheobronchial mucin

1 reference

12 December 2020

Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes

1 reference

12 December 2020

Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis

1 reference

12 December 2020

The effect of sublethal levels of antibiotics on the pathogenicity of Pseudomonas aeruginosa for tracheal tissue

1 reference

12 December 2020

Effects of subminimal inhibitory concentrations of antibiotics on the adherence of Pseudomonas aeruginosa to tracheobronchial mucin

1 reference

12 December 2020

Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis

1 reference

12 December 2020

Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.

1 reference

12 December 2020

Rational parameters for antibiotic therapy in patients with cystic fibrosis

1 reference

12 December 2020

Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay

1 reference

12 December 2020

Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis

1 reference

12 December 2020

Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

Surface morphology of human airway mucosa: normal, carcinoma or cystic fibrosis

1 reference

12 December 2020

Production of lipase by clinical isolates of Pseudomonas cepacia

1 reference

12 December 2020

Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis

1 reference

12 December 2020

Significance of immunologic factors in cystic fibrosis

1 reference

12 December 2020

The importance of extracellular antigens in Pseudomonas cepacia infections

1 reference

12 December 2020

Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis

1 reference

12 December 2020

Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study.

1 reference

12 December 2020

Use of immunoblot detection of serum antibodies in the diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis

1 reference

12 December 2020

Common themes in microbial pathogenicity

1 reference

12 December 2020

Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis

1 reference

12 December 2020

Antibody response to Pseudomonas aeruginosa antigens in cystic fibrosis.

1 reference

12 December 2020

Iron-regulated outer membrane proteins and virulence in Pseudomonas aeruginosa.

1 reference

12 December 2020

The role of bacterial adhesion in cystic fibrosis including the staphylococcal aspect

1 reference

12 December 2020

Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis

1 reference

12 December 2020

Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections

1 reference

12 December 2020

Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom

1 reference

12 December 2020

Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis

1 reference

12 December 2020

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis

1 reference

12 December 2020

Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia

1 reference

12 December 2020

Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management

1 reference

12 December 2020

Pseudomonas aeruginosa recognizes carbohydrate chains containing type 1 (Gal beta 1-3GlcNAc) or type 2 (Gal beta 1-4GlcNAc) disaccharide units

1 reference

12 December 2020

Microbiology of airway disease in patients with cystic fibrosis

1 reference

12 December 2020

Differential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture

1 reference

12 December 2020

Inflammatory markers in cystic fibrosis

1 reference

12 December 2020

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

12 December 2020

Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis

1 reference

12 December 2020

Mucoid Pseudomonas aeruginosa in cystic fibrosis: signal transduction and histone-like elements in the regulation of bacterial virulence

1 reference

12 December 2020

Human tracheobronchial mucin: purification and binding to Pseudomonas aeruginosa

1 reference

12 December 2020

Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia

1 reference

12 December 2020

IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis

1 reference

12 December 2020

Cystic fibrosis in the mouse by targeted insertional mutagenesis

1 reference

12 December 2020

A murine model of chronic mucosal colonization by Pseudomonas aeruginosa

1 reference

12 December 2020

Immunology of cystic fibrosis

1 reference

12 December 2020

Microbiology of lung infection in cystic fibrosis

1 reference

12 December 2020

Lung transplantation for cystic fibrosis

1 reference

12 December 2020

Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration

1 reference

12 December 2020

Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis

1 reference

12 December 2020

Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients

1 reference

12 December 2020

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

1 reference

12 December 2020

Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis

1 reference

12 December 2020

Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684788%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference